{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:41:33Z","timestamp":1788640893543,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"DOI":"10.1093\/humrep\/dei260","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T00:24:07Z","timestamp":1125015847000},"page":"3423-3428","source":"Crossref","is-referenced-by-count":38,"title":["Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval"],"prefix":"10.1093","volume":"20","author":[{"given":"R.E.","family":"Nappi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Brundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"De taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sommacal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ghiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Polatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,8,25]]},"reference":[{"key":"key\n\t\t\t\t20171012102559_BOUSSER-ET-AL-2000","doi-asserted-by":"crossref","unstructured":"Bousser MG , Conard J, Kittner S, de Lignieres B, MacGregor EA, Massiou H, Silberstein SD and Tzourio C (2000) Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia20,155\u2013156.","DOI":"10.1046\/j.1468-2982.2000.00035.x"},{"key":"key\n\t\t\t\t20171012102559_CURTIS-ET-AL-2002","unstructured":"Curtis KM , Chrisman CE and Peterson HB (2002) Contraception for women in selected circumstances. Obstet Gynecol99,1100\u20131112."},{"key":"key\n\t\t\t\t20171012102559_DENNERSTEIN-ET-AL-1988","doi-asserted-by":"crossref","unstructured":"Dennerstein L , Morse C, Burrows G, Oats J, Brown J and Smith M (1988) Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol2,113\u2013120.","DOI":"10.3109\/09513598809023619"},{"key":"key\n\t\t\t\t20171012102559_DESOTO-ET-AL-2003","doi-asserted-by":"crossref","unstructured":"DeSoto MC , Geary DC, Hoard MK, Sheldon MS and Cooper L (2003) Estrogen fluctuations, oral contraceptives and borderline personality. Psychoneuroendocrinology28,751\u2013766.","DOI":"10.1016\/S0306-4530(02)00068-9"},{"key":"key\n\t\t\t\t20171012102559_FIORONI-ET-AL-1995","doi-asserted-by":"crossref","unstructured":"Fioroni L , Martignoni E and Facchinetti F (1995) Changes of neuroendocrine axes in patients with menstrual migraine. Cephalalgia15,297\u2013300.","DOI":"10.1046\/j.1468-2982.1995.1504297.x"},{"key":"key\n\t\t\t\t20171012102559_FIORONI-ET-AL-1996","doi-asserted-by":"crossref","unstructured":"Fioroni L , D\u2019Andrea G, Alecci M, Cananzi A and Facchinetti F (1996) Platelet serotonin pathway in menstrual migraine. Cephalalgia16,427\u2013430.","DOI":"10.1046\/j.1468-2982.1996.1606427.x"},{"key":"key\n\t\t\t\t20171012102559_GOADSBY-ET-AL-2002","doi-asserted-by":"crossref","unstructured":"Goadsby PJ , Lipton RB and Ferrari MD (2002) Migraine\u2014current understanding and treatment. N Engl J Med346,257\u2013270.","DOI":"10.1056\/NEJMra010917"},{"key":"key\n\t\t\t\t20171012102559_GRANELLA-ET-AL-2004","doi-asserted-by":"crossref","unstructured":"Granella F , Sances G, Allais G, Nappi RE, Tirelli A, Benedetto C, Brundu B, Facchinetti F and Nappi G (2004) Characteristics of menstrual and non-menstrual attacks in women with menstrually-related migraine. Cephalalgia24,707\u2013716","DOI":"10.1111\/j.1468-2982.2004.00741.x"},{"key":"key\n\t\t\t\t20171012102559_ICHD-2004","unstructured":"International Classification of Headache Disorders (2004) 2nd edn, Cephalalgia 2004(Suppl 1)."},{"key":"key\n\t\t\t\t20171012102559_MACGREGOR-1997","doi-asserted-by":"crossref","unstructured":"MacGregor EA (1997) Menstruation, sex hormones, and migraine. Neurol Clin15,125\u2013141.","DOI":"10.1016\/S0733-8619(05)70299-1"},{"key":"key\n\t\t\t\t20171012102559_MACGREGOR-2001","doi-asserted-by":"crossref","unstructured":"MacGregor EA (2001) Hormonal contraception and migraine J Fam Plann Reprod Health Care 27,49\u201352.","DOI":"10.1783\/147118901101194912"},{"key":"key\n\t\t\t\t20171012102559_MACGREGOR-2004","doi-asserted-by":"crossref","unstructured":"MacGregor EA (2004) Oestrogen and attacks of migraine with and without aura. Lancet Neurol3,354\u2013361.","DOI":"10.1016\/S1474-4422(04)00768-9"},{"key":"key\n\t\t\t\t20171012102559_MACGREGOR-AND-HACKSHAW-2004","doi-asserted-by":"crossref","unstructured":"MacGregor EA and Hackshaw A (2004) Prevalence of migraine on each day of the natural menstrual cycle. Neurology63,351\u2013353.","DOI":"10.1212\/01.WNL.0000133134.68143.2E"},{"key":"key\n\t\t\t\t20171012102559_MARTIN-ET-AL-2003","doi-asserted-by":"crossref","unstructured":"Martin V , Wernke S, Mandell K, Zoma W, Bean J, Pinney S, Liu J, Ramadan N and Rebar R (2003) Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache43,309\u2013321.","DOI":"10.1046\/j.1526-4610.2003.03065.x"},{"key":"key\n\t\t\t\t20171012102559_MASSIOU-AND-MACGREGOR-2000","doi-asserted-by":"crossref","unstructured":"Massiou H and MacGregor EA (2000) Evolution and treatment of migraine with oral contraceptives. Cephalalgia20,170\u2013174.","DOI":"10.1046\/j.1468-2982.2000.00038.x"},{"key":"key\n\t\t\t\t20171012102559_MCEWEN-2002","doi-asserted-by":"crossref","unstructured":"McEwen B (2002) Estrogen actions throughout the brain. Recent Prog Horm Res57,357\u2013384.","DOI":"10.1210\/rp.57.1.357"},{"key":"key\n\t\t\t\t20171012102559_MUELLER-ET-AL-1985","doi-asserted-by":"crossref","unstructured":"Mueller EA , Murphy DL and Sunderland T (1985) Neuroendocrine effects of m-Chlorophenylpiperazine, a serotonin agonist, in humans. J Clin Endocrinol Metab61,1179\u20131185.","DOI":"10.1210\/jcem-61-6-1179"},{"key":"key\n\t\t\t\t20171012102559_MURRAY-AND-MUSE-1997","doi-asserted-by":"crossref","unstructured":"Murray SC and Muse KN (1997) Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and \u201cadd-back\u201d therapy. Fertil Steril67,390\u2013393.","DOI":"10.1016\/S0015-0282(97)81928-0"},{"key":"key\n\t\t\t\t20171012102559_NAPPI-ET-AL-2003","doi-asserted-by":"crossref","unstructured":"Nappi RE , Sances G, Brundu B, Ghiotto N, Detaddei S, Biancardi C, Polatti F and Nappi G (2003) Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus. Neuroendocrinology78,52\u201360.","DOI":"10.1159\/000071706"},{"key":"key\n\t\t\t\t20171012102559_SCHMIDT-ET-AL-2000","doi-asserted-by":"crossref","unstructured":"Schmidt PJ , Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH and Rubinow DR (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol183,414\u2013420.","DOI":"10.1067\/mob.2000.106004"},{"key":"key\n\t\t\t\t20171012102559_SEEGER-ET-AL-2000","doi-asserted-by":"crossref","unstructured":"Seeger H , Ludtke R, Graser T, Wallwiener D and Mueck AO (2000) Effect of oral contraceptives on the urinary excretion of biochemical markers indicating vasoactive action. J Clin Pharm Ther25,221\u2013226.","DOI":"10.1046\/j.1365-2710.2000.00283.x"},{"key":"key\n\t\t\t\t20171012102559_SHAARAWY-ET-AL-1982","doi-asserted-by":"crossref","unstructured":"Shaarawy M , Fayad M, Nagui AR and Abdel-Azim S (1982) Serotonin metabolism and depression in oral contraceptive users. Contraception26,193\u2013204.","DOI":"10.1016\/0010-7824(82)90087-7"},{"key":"key\n\t\t\t\t20171012102559_SILBERSTEIN-1992","unstructured":"Silberstein SD (1992) The role of sex hormones in headache. Neurology42,37\u201342."},{"key":"key\n\t\t\t\t20171012102559_SILBERSTEIN-AND-MERRIAM-1999","unstructured":"Silberstein S and Merriam G (1999) Sex hormones and headache 1999 (menstrual migraine). Neurology53, S3\u2013S13."},{"key":"key\n\t\t\t\t20171012102559_SOMMERVILLE-1975","doi-asserted-by":"crossref","unstructured":"Sommerville BW (1975) Estrogen-withdrawal migraine. Neurology25,239\u2013244.","DOI":"10.1212\/WNL.25.3.239"},{"key":"key\n\t\t\t\t20171012102559_SULAK-ET-AL-2000","unstructured":"Sulak PJ , Scow RD, Preece C, Riggs MW and Kuehl TJ (2000) Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol95,261\u2013266."},{"key":"key\n\t\t\t\t20171012102559_SULAK-ET-AL-2002","doi-asserted-by":"crossref","unstructured":"Sulak PJ , Kuehl TJ, Ortiz M and Shull BL (2002) Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol186,1142\u20131149.","DOI":"10.1067\/mob.2002.122988"},{"key":"key\n\t\t\t\t20171012102559_TUITEN-ET-AL-1995","doi-asserted-by":"crossref","unstructured":"Tuiten A , Panhuysen G, Koppeschaar H, Fekkes D, Pijl H, Frolich M, Krabbe P and Everaerd V (1995) Stress, serotoninergic function, and mood in users of oral contraceptives. Psychoneuroendocrinology20,323\u2013334.","DOI":"10.1016\/0306-4530(94)00063-G"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/20\/12\/3423\/9543515\/dei260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T13:24:45Z","timestamp":1552915485000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/20\/12\/3423\/2913785\/Estradiol-supplementation-modulates-neuroendocrine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,25]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2005,8,25]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei260","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,12]]},"published":{"date-parts":[[2005,8,25]]}}}